FindTrial
Sign In

Study of pushkarmuladi churna in the management of Vatik kasa

A clinical study to evaluate the efficacy of pushkarmuladi churna in the management of Vatik kasa w.s.r to recurrent U.R.T.I in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018374
Enrollment
30
Registered
2019-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

Intervention1: Pushkarmuladi Churna: Single group of 30 patients will be given One masha of pushkarmuladi Churna at 1 year of age in increasing dose according to age upto 16 year,will be given for 1 m

Sponsors

Rishikul Campus
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age >1 year Seasonal and recurrent cough without sputum.

Exclusion criteria

Exclusion criteria: Age 16 year. Cough associated with other respiratory disorder like bronchial asthma. Tuberculosis, pulmonary eosinophilia,Loffler syndrome or any other systemic disease. Cough associated with severe malnutrition. Cough associated with neurological disorder.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Pushkarmuladi Churna in Vatik Kasa, subjectively all sign and symptoms were given grading depending upon their severity.Timepoint: 1 Month—

Secondary

MeasureTime frame
Exacerbation in signs and symptoms.Timepoint: 7 days.—

Countries

India

Contacts

Public ContactDr keerti Verma

Rishikul Campus, Uttarakhand ayurveda University, Haridwar.

Keerti.vrm@gmail.com9997777833

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026